PMC:7299399 / 2561-2837 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T5","span":{"begin":190,"end":194},"obj":"Body_part"}],"attributes":[{"id":"A5","pred":"fma_id","subj":"T5","obj":"http://purl.org/sig/ont/fma/fma74402"}],"text":", or modification of the host defense mechanisms at all levels.1 Their ability to transfer genes with high efficiency inspired the development of noninfectious recombinant viral vectors for gene-therapy applications, beginning in 1990.2−4 Efforts were then underway to improve"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T36336","span":{"begin":91,"end":96},"obj":"http://purl.obolibrary.org/obo/OGG_0000000002"},{"id":"T52287","span":{"begin":190,"end":194},"obj":"http://purl.obolibrary.org/obo/OGG_0000000002"}],"text":", or modification of the host defense mechanisms at all levels.1 Their ability to transfer genes with high efficiency inspired the development of noninfectious recombinant viral vectors for gene-therapy applications, beginning in 1990.2−4 Efforts were then underway to improve"}

{"project":"2_test","denotations":[{"id":"32519842-27449616-158444","span":{"begin":63,"end":64},"obj":"27449616"},{"id":"32519842-11642817-158445","span":{"begin":235,"end":236},"obj":"11642817"},{"id":"32519842-32341506-158446","span":{"begin":237,"end":238},"obj":"32341506"}],"text":", or modification of the host defense mechanisms at all levels.1 Their ability to transfer genes with high efficiency inspired the development of noninfectious recombinant viral vectors for gene-therapy applications, beginning in 1990.2−4 Efforts were then underway to improve"}